Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Endocrinology

• Publication date

  2012-09-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/me.2011-1314PMID 23023562PMCID PMC3487621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pioneer factors in hormone-dependent cancers

  2012cited by this paper
• Cross-talk between the Androgen Receptor and the Liver X Receptor

  2011cited by this paper
• Pioneer factors: directing transcriptional regulators within the chromatin environment.

  2011cited by this paper
• Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women

  2011cited by this paper
• Targeting androgen receptor in estrogen receptor-negative breast cancer.

  2011cited by this paper
• Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism.

  2011cited by this paper
• Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1

  2011cited by this paper
• FOXA1 is a critical determinant of Estrogen Receptor function and endocrine response

  2010cited by this paper
• Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences

  2010cited by this paper
• Next-generation genomics: an integrative approach

  2010cited by this paper
• Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs.

  2010cited by this paper
• Research Resource: The androgen receptor modulates expression of genes with critical roles in muscle development and function.

  2010cited by this paper
• Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

  2010cited by this paper
• Chromatin Interaction Analysis Using Paired‐End Tag Sequencing

  2010cited by this paper
• Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.

  2010cited by this paper
• Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

  2009cited by this paper
• A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin.

  2009cited by this paper
• Androgens and the breast

  2009cited by this paper
• Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

  2009cited by this paper
• ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands

  2009cited by this paper
• Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.

  2009cited by this paper
• Unique ERalpha cistromes control cell type-specific gene regulation.

  2008cited by this paper
• Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity

  2008cited by this paper
• An integrated system CisGenome for analyzing ChIP-chip and ChIP-seq data

  2008cited by this paper
• Genome-Wide Analysis of Transcription Factor Binding Sites Based on ChIP-Seq Data

  2008cited by this paper
• FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology

  2008cited by this paper
• Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen

  2008cited by this paper
• A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

  2007cited by this paper
• Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis

  2007cited by this paper
• JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update

  2007cited by this paper
• Cell- and gene-specific regulation of primary target genes by the androgen receptor.

  2007cited by this paper
• Whole-Genome Cartography of Estrogen Receptor α Binding Sites

  2007cited by this paper
• New androgen receptor genomic targets show an interaction with the ETS1 transcription factor

  2007cited by this paper
• Adjusting batch effects in microarray expression data using empirical Bayes methods.

  2007cited by this paper
• An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells

  2007cited by this paper
• Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.

  2006cited by this paper
• Estrogen receptor target gene: an evolving concept.

  2006cited by this paper
• Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52

  2006cited by this paper
• Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.

  2006cited by this paper
• An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

  2006cited by this paper
• Genome-wide analysis of estrogen receptor binding sites

  2006cited by this paper
• Endogenous Coactivator ARA70 Interacts with Estrogen Receptor α (ERα) and Modulates the Functional ERα/Androgen Receptor Interplay in MCF-7 Cells*

  2005cited by this paper
• Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.

  2005cited by this paper
• A high-resolution map of active promoters in the human genome

  2005cited by this paper
• Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

  2005cited by this paper
• Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.

  2005cited by this paper
• Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity

  2005cited by this paper
• Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.

  2005cited by this paper
• Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.

  2005cited by this paper
• limma: Linear Models for Microarray Data

  2005cited by this paper
• Estrogen Receptor α Binds to Peroxisome Proliferator–Activated Receptor Response Element and Negatively Interferes with Peroxisome Proliferator–Activated Receptor γ Signaling in Breast Cancer Cells

  2005cited by this paper
• The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.

  2004cited by this paper
• WebLogo: a sequence logo generator.

  2004cited by this paper
• Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.

  2003cited by this paper
• Variance stabilization applied to microarray data calibration and to the quantification of differential expression

  2002cited by this paper
• The chicken vitellogenin II gene is flanked by a GATA factor-dependent estrogen response unit.

  1996cited by this paper
• Androgens induce divergent proliferative responses in human breast cancer cell lines.

  1995cited by this paper
• Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.

  1992cited by this paper
• Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line.

  1989cited by this paper
• Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.

  1978cited by this paper
• Fluoxymesterone therapy in advanced breast cancer.

  1958cited by this paper
• Estrogen Receptor (cid:1) Controls a Gene Network in Luminal-Like Breast Cancer Cells Comprising Multiple Transcription Factors and MicroRNAs

  year unknowncited by this paper

• Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?

  2025cites this paper
• Regulatory mechanisms of steroid hormone receptors on gene transcription through chromatin interaction and enhancer reprogramming

  2024cites this paper
• Estrogen’s sex-specific effects on ischemic cell death and estrogen receptor mRNA expression in rat cortical organotypic explants

  2024cites this paper
• DREAM On, DREAM Off: A Review of the Estrogen Paradox in Luminal A Breast Cancers

  2024cites this paper
• An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers

  2023cites this paper
• Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.

  2023cites this paper
• Probing the mechanism of action (MOA) of Solanum nigrum Linn against breast cancer using network pharmacology and molecular docking

  2023cites this paper
• Androgen Receptor driven gene score identifies tumors with Epithelial to Mesenchymal Transition features in triple negative breast cancer

  2023cites this paper
• Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients

  2023cites this paper
• Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1–NDRG1 deregulation

  2023cites this paper
• Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line

  2022cites this paper
• Impact of Androgen Receptor Expression and the AR:ER Ratio on the Survival Outcomes in the Diverse Subgroups of Vietnamese Breast Cancer: A Single Institutional Retrospective Cohort Analysis

  2022cites this paper
• Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis.

  2022cites this paper
• Androgen receptor in breast cancer: The “5W” questions

  2022cites this paper
• The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers

  2022cites this paper
• Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer

  2022cites this paper
• Intrinsic Subtypes and Androgen Receptor Gene Expression in Primary Breast Cancer. A Meta-Analysis

  2021cites this paper
• Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer

  2021cites this paper
• Obesity and Androgen Receptor Signaling: Associations and Potential Crosstalk in Breast Cancer Cells

  2021cites this paper
• Targeting YY1 in cancer through histone acetylation

  2021cites this paper
• Differential Expression of Androgen Receptor in Type I and Type II Endometrial Carcinomas: A Clinicopathological Analysis and Correlation with Outcome

  2021cites this paper
• Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis

  2021cites this paper
• The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk?

  2021cites this paper
• Androgen Receptor in Breast Cancer: From Bench to Bedside

  2020cites this paper
• Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer

  2020cites this paper
• Retinoic Acid-Related Orphan Receptor alpha 1 (RORα1) Induction of AKR1C3 Promotes MCF-7 Breast Cancer Cell Proliferation and Tamoxifen-Resistance which is Suppressed by Melatonin

  2020cites this paper
• Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights

  2020cites this paper
• The impact of androgen receptor (AR) and histone deacetylase 1 (HDAC1) expression on the prognosis of ductal carcinoma in situ (DCIS)

  2020cites this paper
• An Omic and Multidimensional Spatial Atlas from Serial Biopsies of an Evolving Metastatic Breast Cancer

  2020cites this paper
• Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer.

  2020cites this paper
• The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ

  2020cites this paper
• Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer.

  2020cites this paper
• TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets

  2020cites this paper
• AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells

  2019cites this paper
• Androgen receptor: A promising therapeutic target in breast cancer

  2019cites this paper
• Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98

  2019cites this paper
• Combined Androgen receptor blockade overcomes the resistance of breast cancer cells to palbociclib

  2019cites this paper
• ANTI-proliferative transcriptional effects of medroxyprogesterone acetate in Estrogen receptor positive breast cancer cells are predominantly mediated by ThE progesterone receptor.

  2019cites this paper
• Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

  2019cites this paper
• Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

  2019cites this paper
• Hormone Therapy and Breast Cancer: Emerging Steroid Receptor Mechanisms.

  2018cites this paper
• Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

  2018cites this paper
• Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?

  2018cites this paper
• Improvements to the Vulva, Vestibule, Urethral Meatus, and Vagina in Women Treated With Ospemifene for Moderate to Severe Dyspareunia: A Prospective Vulvoscopic Pilot Study

  2018cites this paper
• The role of the AR/ER ratio in ER-positive breast cancer patients.

  2018cites this paper
• Androgen blockade based clinical trials landscape in triple negative breast cancer.

  2018cites this paper
• Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44+/CD24− and ALDH1+): Prognostic Implications in Invasive Breast Cancer12

  2018cites this paper
• Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer

  2018cites this paper
• Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers

  2018cites this paper
• The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology

  2018cites this paper
• Hormone-Targeted Therapy and Resistance

  2018cites this paper
• The Role of Androgen Receptor Signalling in Endocrine Resistant Breast Cancer

  2018influential citation
• Investigating the mechanism of action of hormones used in hormone replacement therapy via estrogen receptor subtypes and the influence of the progesterone receptor

  2018cites this paper
• "New molecular approches using AR, FOXA1 and HER2 for outcome classification of estrogen Receptor-Positive (ER+) breast cancers”

  2018influential citation
• Expression of Androgen Receptor and Cancer Stem Cell Markers ( CD 44 + / CD 24 − and ALDH 1 + ) : Prognostic Implications in Invasive Breast Cancer 1 , 2

  2018cites this paper
• Post-menopausal breast cancer: from estrogen to androgen receptor

  2017cites this paper
• Androgen receptor in estrogen receptor positive breast cancer: Beyond expression.

  2017cites this paper
• The miR-96/RARγ signaling axis governs androgen signaling and prostate cancer progression

  2017cites this paper
• AR Signaling in Breast Cancer

  2017cites this paper
• Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor–Positive Breast Cancer Models with a Distinct Mechanism of Action

  2017influential citation
• Identification of rare gene variants in South African breast cancer families through next generation sequencing

  2017cites this paper
• Engineering and Evaluating Fluorescent Tools for Endoplasmic Reticulum Zinc

  2017cites this paper
• Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders

  2017cites this paper
• Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers

  2017cites this paper
• Genome-Wide Mapping of In Vivo ER&agr;–Binding Sites in Male Mouse Efferent Ductules

  2017cites this paper
• Cooperative Dynamics of AR and ER Activity in Breast Cancer

  2016cites this paper
• Endocrine disruptor actions through receptor crosstalk

  2016cites this paper
• GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome

  2016cites this paper
• Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy.

  2016cites this paper
• The role of estrogen receptor α and the androgen receptor in human breast cancer

  2016cites this paper
• Crosstalk between the androgen and estrogen receptors in breast cancer

  2016cites this paper
• Cistrome of the aldosterone‐activated mineralocorticoid receptor in human renal cells

  2015cites this paper
• Progesterone action in breast, uterine, and ovarian cancers.

  2015cites this paper
• Steroid Receptors in the Uterus and Ovary

  2015cites this paper
• A Functional Genetic Study of Sexual Dimorphism and Behavioral Ecology in Chrysomya rufifacies (Diptera: Calliphoridae)

  2015cites this paper
• The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype

  2015cites this paper
• Hormone-Sensing Mammary Epithelial Progenitors: Emerging Identity and Hormonal Regulation

  2015cites this paper
• Steroid receptor crosstalk in breast cancer cells.

  2014cites this paper
• In Vitro Chronic Administration of ERbeta Selective Ligands and Prostate Cancer Cell Growth: Hypotheses on the Selective Role of 3beta-Adiol in AR-Positive RV1 Cells

  2014influential citation
• Molecular determinants of context-dependent progesterone receptor action in breast cancer

  2014cites this paper
• β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression

  2014cites this paper
• Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

  2014cites this paper
• A pro‐tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment

  2014cites this paper
• Complexities of androgen receptor signalling in breast cancer.

  2014cites this paper
• Personalized Medicine and Imaging Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer

  2014cites this paper
• Evidence of androgen action in endometrial and ovarian cancers.

  2014cites this paper
• Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Δ(4)-tibolone.

  2014influential citation
• The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.

  2014cites this paper
• Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor.

  2014influential citation
• Androgens in breast cancer 21 : 4 T 162 relevant levels in the circulation of women

  2014cites this paper
• A CASE OF BILATERAL SYNCHRONOUS APOCRINE CARCINOMAS ASSOCIATED WITH NEUROFIBROMATOSIS

  2013cites this paper
• Prostate Cancer

  2013cites this paper
• Alterations in replication timing of cancer‐related genes in malignant human breast cancer cells

  2013cites this paper
• Postmenopausal breast cancer, androgens, and aromatase inhibitors

  2013cites this paper
• Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer.

  2013cites this paper
• Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression

  2013cites this paper
• Biology and Clinical Relevance of Estrogen Receptors in Prostate Cancer

  2013cites this paper